Publication | Open Access

The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk

PsychiatryCardiovascular DiseasePsychotropic MedicationTreatment And PreventionPsychopharmacologyPharmacotherapyHivSecond-generation AntipsychoticsMedicinePublic HealthLong-term Antiretroviral TherapyIncreased Cardiovascular RiskEpidemiology